INCY $85.34 -1.74 (-2.00%)

Fri, Mar 22, 2019

Incyte Corp is a Health Care stock that trades on the NASDAQ with a market cap of $18.64 Billion

What is your rating of INCY?

Add INCY to your portfolio?


Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant, which Eli Lilly licenses, and oncology drug Iclusig for chronic myeloid leukemia. Incyte's pipeline includes a broad array of oncology and autoimmune programs, including next-generation JAK inhibitor itacitinib. http://www.incyte.com


For more information and analysis of INCY, visit Bloomberg, Google Finance, Nasdaq & Yahoo Finance.

Trending Fri, Mar 22, 2019

This list of trending stocks may change throughout the trading day.


Symbol Surfing Login Sign In

  • Rate symbols "Buy", "Hold" or "Sell"
  • Create a watchlist or portfolio
  • Download Data CSV files

Ratings 0 Portfolio 0

Incyte Corp Stock Charts

The 5 year and 1 year stock charts are below.


INCY Stock Price

Below are a few key dates for the stock price.


Year To Date

Mar
22
Friday

The most recent stock price is $85.34.

The Year To Date (YTD) return is +34.27%.

52 Week Low

Dec 2018
24
Monday

The 52 Week Low stock price is $58.50 set on Mon, Dec 24, 2018 which is 89 days ago.

The current price per share is 45.88% above the 52 week low.

52 Week High

Mar
01
Friday

The 52 Week High stock price is $88.17 set on Fri, Mar 1, 2019 which is 22 days ago.

The current price per share is -3.21% below the 52 week high.

All Time High

Mar 2017
15
Wednesday

The All Time High stock price is $152.66 set on Wed, Mar 15, 2017 which is 738 days ago.

The current price per share is -44.10% below the all time high.

INCY Stock Split History

Incyte Corp has had 2 stock splits.

Split Date Split Ratio
Fri, Sep 1, 20002 for 1
Mon, Nov 10, 19972 for 1

Earnings

Below is the EPS, P/E Ratio and Earnings Date.


The Earnings Per Share (EPS) is $0.33.

The Price To Earnings (P/E) Ratio is 170.75.

Earnings Dates

Stocks can make big percentage moves on the earnings announcement.

Companies announce earnings either before the market open or after the close.

Oct 2018
30
Tuesday

The Earnings Release Date for Incyte Corp was Tue, Oct 30, 2018.

Since this earnings release 144 days ago, the stock price is up by +34.78%.

Feb
14
Thursday

The most recent Earnings Release Date was on Thu, Feb 14, 2019, which was 37 days ago.

Since this earnings date, the stock price is up by +5.28%.

Incyte Corp Dividend

Below is important Dividend information.


INCY currently does not pay a dividend.

You may like this list of best dividend stocks of 2019.

Industry Stocks

Below are some other Biotech & Pharma industry stocks like Incyte Corp.